108 related articles for article (PubMed ID: 22534418)
1. Characterization of negatively charged phospholipids and cell origin of microparticles in women with gestational vascular complications.
Katzenell S; Shomer E; Zipori Y; Zylberfisz A; Brenner B; Aharon A
Thromb Res; 2012 Sep; 130(3):479-84. PubMed ID: 22534418
[TBL] [Abstract][Full Text] [Related]
2. Placenta-derived microparticles.
Aharon A; Brenner B
Thromb Res; 2013 Jan; 131 Suppl 1():S22-4. PubMed ID: 23452734
[TBL] [Abstract][Full Text] [Related]
3. Microparticles and pregnancy complications.
Aharon A; Brenner B
Thromb Res; 2011 Feb; 127 Suppl 3():S67-71. PubMed ID: 21262446
[TBL] [Abstract][Full Text] [Related]
4. Involvement of microparticles in diabetic vascular complications.
Tsimerman G; Roguin A; Bachar A; Melamed E; Brenner B; Aharon A
Thromb Haemost; 2011 Aug; 106(2):310-21. PubMed ID: 21713319
[TBL] [Abstract][Full Text] [Related]
5. Circulating microparticles in severe preeclampsia.
Marques FK; Campos FM; Filho OA; Carvalho AT; Dusse LM; Gomes KB
Clin Chim Acta; 2012 Dec; 414():253-8. PubMed ID: 23041217
[TBL] [Abstract][Full Text] [Related]
6. Circulating cell-derived microparticles in severe preeclampsia and in fetal growth restriction.
Alijotas-Reig J; Palacio-Garcia C; Farran-Codina I; Ruiz-Romance M; Llurba E; Vilardell-Tarres M
Am J Reprod Immunol; 2012 Feb; 67(2):140-51. PubMed ID: 21992597
[TBL] [Abstract][Full Text] [Related]
7. Microvesicles of pregnant women receiving low molecular weight heparin improve trophoblast function.
Shomer E; Katzenell S; Zipori Y; Rebibo-Sabbah A; Brenner B; Aharon A
Thromb Res; 2016 Jan; 137():141-147. PubMed ID: 26639203
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of microparticles at 24 weeks of gestation do not predict subsequent pregnancy complications.
Salomon O; Katz BZ; Dardik R; Livnat T; Steinberg DM; Achiron R; Seligsohn U
Fertil Steril; 2009 Aug; 92(2):682-7. PubMed ID: 18692836
[TBL] [Abstract][Full Text] [Related]
9. Circulating microparticles as indicators of peripartum cardiomyopathy.
Walenta K; Schwarz V; Schirmer SH; Kindermann I; Friedrich EB; Solomayer EF; Sliwa K; Labidi S; Hilfiker-Kleiner D; Böhm M
Eur Heart J; 2012 Jun; 33(12):1469-79. PubMed ID: 22307461
[TBL] [Abstract][Full Text] [Related]
10. Microparticle source and tissue factor expression in pregnancy.
Wong AE; Kwaan HC; Grobman WA; Weiss I; Wong CA
Ann Hematol; 2015 Aug; 94(8):1285-90. PubMed ID: 25823853
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric analysis of cell membrane microparticles.
Gelderman MP; Simak J
Methods Mol Biol; 2008; 484():79-93. PubMed ID: 18592174
[TBL] [Abstract][Full Text] [Related]
12. Maternal plasma from pregnant women with umbilical placental vascular disease does not affect endothelial cell mRNA expression of nitric oxide synthase.
Wang X; Athayde N; Trudinger B
J Soc Gynecol Investig; 2004 Apr; 11(3):149-53. PubMed ID: 15051034
[TBL] [Abstract][Full Text] [Related]
13. [Circulating endothelial microparticles: a new marker of vascular injury].
Boulanger CM; Leroyer AS; Amabile N; Tedgui A
Ann Cardiol Angeiol (Paris); 2008 Jun; 57(3):149-54. PubMed ID: 18579117
[TBL] [Abstract][Full Text] [Related]
14. Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus.
Nielsen CT; Østergaard O; Johnsen C; Jacobsen S; Heegaard NH
Arthritis Rheum; 2011 Oct; 63(10):3067-77. PubMed ID: 21702008
[TBL] [Abstract][Full Text] [Related]
15. Circulating cell-derived microparticles in women with pregnancy loss.
Alijotas-Reig J; Palacio-Garcia C; Farran-Codina I; Zarzoso C; Cabero-Roura L; Vilardell-Tarres M
Am J Reprod Immunol; 2011 Sep; 66(3):199-208. PubMed ID: 21276118
[TBL] [Abstract][Full Text] [Related]
16. Microparticles and type 2 diabetes.
Leroyer AS; Tedgui A; Boulanger CM
Diabetes Metab; 2008 Feb; 34 Suppl 1():S27-32. PubMed ID: 18358424
[TBL] [Abstract][Full Text] [Related]
17. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
[TBL] [Abstract][Full Text] [Related]
18. Microparticles, vascular function, and atherothrombosis.
Rautou PE; Vion AC; Amabile N; Chironi G; Simon A; Tedgui A; Boulanger CM
Circ Res; 2011 Aug; 109(5):593-606. PubMed ID: 21852557
[TBL] [Abstract][Full Text] [Related]
19. Microparticles of pregnant women and preeclamptic patients activate endothelial cells in the presence of monocytes.
Lok CA; Snijder KS; Nieuwland R; Van Der Post JA; de Vos P; Faas MM
Am J Reprod Immunol; 2012 Mar; 67(3):206-15. PubMed ID: 22011169
[TBL] [Abstract][Full Text] [Related]
20. Chronic renal failure is accompanied by endothelial activation and a large increase in microparticle numbers with reduced procoagulant capacity.
Trappenburg MC; van Schilfgaarde M; Frerichs FC; Spronk HM; ten Cate H; de Fijter CW; Terpstra WE; Leyte A
Nephrol Dial Transplant; 2012 Apr; 27(4):1446-53. PubMed ID: 21873622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
